Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
| Autor: | Pratley, Richard, Amod, Aslam, Hoff, Søren Tetens, Kadowaki, Takashi, Lingvay, Ildiko, Nauck, Michael, Pedersen, Karen Boje, Saugstrup, Trine, Meier, Juris J |
|---|---|
| Zdroj: | In The Lancet 6-12 July 2019 394(10192):39-50 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|